Separately, HC Wainwright lifted their price target on Vizsla Silver from $2.00 to $2.75 in a research report on Wednesday.
Vizsla Silver Price Performance
Shares of VZLA stock traded up $0.04 during trading hours on Wednesday, reaching $1.36. The company’s stock had a trading volume of 233,953 shares, compared to its average volume of 176,560. The company has a market capitalization of $244.35 million and a PE ratio of -15.11. Vizsla Silver has a one year low of $0.91 and a one year high of $2.24. The business’s fifty day moving average is $1.16.
Institutional Investors Weigh In On Vizsla Silver
Hedge funds have recently made changes to their positions in the company. FNY Investment Advisers LLC boosted its position in shares of Vizsla Silver by 25.0% during the third quarter. FNY Investment Advisers LLC now owns 75,000 shares of the company’s stock valued at $86,000 after purchasing an additional 15,000 shares in the last quarter. U S Global Investors Inc. boosted its holdings in Vizsla Silver by 33.3% in the third quarter. U S Global Investors Inc. now owns 1,000,000 shares of the company’s stock worth $1,143,000 after acquiring an additional 250,000 shares in the last quarter. Finally, MMCAP International Inc. SPC boosted its holdings in Vizsla Silver by 2.3% in the second quarter. MMCAP International Inc. SPC now owns 2,505,976 shares of the company’s stock worth $2,648,000 after acquiring an additional 57,500 shares in the last quarter. 16.55% of the stock is currently owned by institutional investors.
About Vizsla Silver
Vizsla Silver Corp. engages in the acquisition, exploration, and development of precious and base metal assets. The company explores for gold, silver, and coper deposits. Its flagship project is the Panuco-Copala silver gold district located in Sinaloa, Mexico. The company was formerly known as Vizsla Resources Corp.
- Get a free copy of the StockNews.com research report on Vizsla Silver (VZLA)
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Vizsla Silver Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vizsla Silver and related companies with MarketBeat.com's FREE daily email newsletter.